Citation Impact
Citing Papers
Insulin Resistance and a Diabetes Mellitus-Like Syndrome in Mice Lacking the Protein Kinase Akt2 (PKBβ)
2001 StandoutScience
Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro
2006 StandoutNobel
An Engineered Microbial Platform for Direct Biofuel Production from Brown Macroalgae
2012 StandoutScienceNobel
Linkage Map ofEscherichia coliK-12, Edition 10: The Traditional Map
1998
The amino acid sequence of yeast phosphoglycerate mutase
1982
Deletion of methylglyoxal synthase gene (mgsA) increased sugar co-metabolism in ethanol-producing Escherichia coli
2009
Short-Term Effects of Nose-Only Cigarette Smoke Exposure on Glutathione Redox Homeostasis, Cytochrome P450 1A1/2 and Respiratory Enzyme Activities in Mice Tissues
2013 Standout
Conformational Studies on Plasminogen Activator Inhibitor (PAI-1) in Active, Latent, Substrate, and Cleaved Forms
1995
Multiple Biomarkers for the Prediction of First Major Cardiovascular Events and Death
2006 Standout
VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation
1999 Standout
Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomised trial
1999
Increased expression of plasminogen activator and plasminogen activator inhibitor during liver fibrogenesis of rats: role of stellate cells
1999
Paraneoplastic Syndromes Involving the Nervous System
2003 Standout
Bivalirudin during Primary PCI in Acute Myocardial Infarction
2008 Standout
The metabolic syndrome
2010 Standout
Tissue Destruction by Neutrophils
1989 Standout
A longitudinal study of biochemical variables in women at risk of preeclampsia
2002
Abdominal aortic aneurysm
2005 Standout
Cigarette Smoke Exposure Promotes Arterial Thrombosis and Vessel Remodeling after Vascular Injury in Apolipoprotein E-Deficient Mice
2008
Development and Disease in Proteinase-Deficient Mice
1998
Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome
2005 Standout
Hemostatic Factors and the Risk of Myocardial Infarction or Sudden Death in Patients with Angina Pectoris
1995 Standout
Plasminogen activator inhibitor-1 (PAI-1) content in platelets from healthy individuals genotyped for the 4G/5G polymorphism in the PAI-1 gene
1997
Angiogenesis in cancer and other diseases
2000 StandoutNature
Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus
2010
The Fibrinolytic System of the Vessel Wall and Its Role in the Control of Thrombosis
1990
Platelet Activation and Atherothrombosis
2007 Standout
The metabolic syndrome
2005 Standout
Aberrant Wound Healing and TGF-β Production in the Autoimmune-Prone MRL/+ Mouse
1999
Extracellular matrix and matrix receptors in blood–brain barrier formation and stroke
2011
Pre-eclampsia
2005 Standout
Vascular development and disorders: Molecular analysis and pathogenic insights
1998
Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial: Study design and rationale
2004
Activation of both coagulation and fibrinolysis in childhood hemolytic uremic syndrome
1998
The role of thrombin receptors PAR1 and PAR4 for PAI-1 storage, synthesis and secretion by human platelets
2012 StandoutNobel
Importance of the Hinge Region between α-Helix F and the Main Part of Serpins, Based upon Identification of the Epitope of Plasminogen Activator Inhibitor Type 1 Neutralizing Antibodies
2000
Absence of enhanced systemic inflammatory response at 18 weeks of gestation in women with subsequent pre‐eclampsia
2002
Fibrinolytic response to venous occlusion is decreased in patients after Kawasaki disease
2003
Development, maintenance and disruption of the blood-brain barrier
2013 Standout
Type 2 diabetes
2017 Standout
Calcium-dependent Stabilization of Type I Plasminogen Activator Inhibitor within Plateletα-Granules
1996
Metformin hydrochloride in the treatment of type 2 diabetes mellitus: A clinical review with a focus on dual therapy
2003
The potential role of platelet microparticles in atherosclerosis
2005
The long-term effects of metoprolol and epanolol on tissue-type plasminogen activator and plasminogen activator inhibitor 1 in patients with ischaemic heart disease
1994
Hemodynamic Shear Stress and Its Role in Atherosclerosis
1999 Standout
An Antibody Fragment from a Phage Display Library Competes for Ligand Binding to the Low Density Lipoprotein Receptor Family and Inhibits Rhinovirus Infection
1995 StandoutNobel
The activated form of gelatinase B/matrix metalloproteinase-9 is associated with diabetic vitreous hemorrhage
2006
Polycystic Ovary Syndrome
2005 Standout
The role of glyoxalase I in the detoxification of methylglyoxal and in the activation of the KefB K+ efflux system in Escherichia coli
1998
Metformin
1996
Hemostatic alterations in cancer patients
1992
Plasminogen activator inhibitor-type 1: its plasma determinants and relation with cardiovascular risk
2004
Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus
2010
Role of Plasminogen-Activator Inhibitor Type 1 in the Pathogenesis and Outcome of the Hemolytic Uremic Syndrome
1992
Neonatal bleeding in transgenic mice expressing urokinase-type plasminogen activator
1990
Transgenic mouse models in angiogenesis and cardiovascular disease
2000
Engineered mutants of HGF/SF with reduced binding to heparan sulphate proteoglycans, decreased clearance and enhanced activity in vivo
1998 StandoutNobel
TRIM28 prevents autoinflammatory T cell development in vivo
2012 StandoutNobel
Soluble Endoglin and Other Circulating Antiangiogenic Factors in Preeclampsia
2006 Standout
Human DNA Damage Checkpoint Protein hRAD9 Is a 3′ to 5′ Exonuclease
2000 StandoutNobel
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association
2017 Standout
The pathogenesis of atherosclerosis: a perspective for the 1990s
1993 StandoutNature
Implantation and the placenta: key pieces of the development puzzle
1994 StandoutScience
Molecular cloning of cDNA for human complement component C1s
1987
Lysis of Platelet‐rich Thrombi: The Role of PAI–1a
1992
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
2008 Standout
Standardized Bleeding Definitions for Cardiovascular Clinical Trials
2011 Standout
Plasminogen activator inhibitors
1987
Platelets inhibit fibrinolysis in vitro by both plasminogen activator inhibitor-1-dependent and -independent mechanisms
1994
Methylglyoxal Synthetase, Enol-Pyruvaldehyde, Glutathione and the Glyoxalase System
2002 StandoutNobel
Platelets synthesize large amounts of active plasminogen activator inhibitor 1
2004
Serpin Structure, Mechanism, and Function
2002 Standout
Type 2 diabetes: principles of pathogenesis and therapy
2005 Standout
Platelets and platelet adhesion support angiogenesis while preventing excessive hemorrhage
2006
Fluid Flow Stimulates Tissue Plasminogen Activator Secretion by Cultured Human Endothelial Cells
1989 Science
The active and the inactive plasminogen activator inhibitor from human endothelial cell conditioned medium are immunologically and functionally related to each other
1986
VEGF Secreted by Hypoxic Müller Cells Induces MMP-2 Expression and Activity in Endothelial Cells to Promote Retinal Neovascularization in Proliferative Diabetic Retinopathy
2013 StandoutNobel
Factors contributing to increased vascular fibrinolytic activity in mongrel dogs.
1993
The mechanism of the reaction between human plasminogen-activator inhibitor 1 and tissue plasminogen activator
1990 StandoutNobel
Low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor is an hepatic receptor for tissue-type plasminogen activator.
1992
Biological implications of a 3 å structure of dimeric antithrombin
1994
Determinants of binding and internalization of tissue-type plasminogen activator by human vascular smooth muscle and endothelial cells
1993
A genetically clamped renin transgene for the induction of hypertension
2002 StandoutNobel
Interaction of single-chain urokinase-type plasminogen activator with human endothelial cells.
1990 StandoutNobel
Chronic Thromboembolic Pulmonary Hypertension
2006 Standout
Endocytosis of urokinase-plasminogen activator inhibitor type 1 complexes bound to a chimeric transmembrane urokinase receptor.
1994 StandoutNobel
COAGULATION DISORDERS IN CANCER
1996
The yeast SEC53 gene encodes phosphomannomutase.
1988 StandoutNobel
Prevention of Aneurysm Development and Rupture by Local Overexpression of Plasminogen Activator Inhibitor-1
1998
Inactivation of plasminogen activator inhibitor by oxidants
1986
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Coronary Plaque Disruption
1995 Standout
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease
2004 Standout
Low-affinity heparin stimulates the inactivation of plasminogen activator inhibitor-1 by thrombin
1994
Tumors: Wounds That Do Not Heal
1986 Standout
Complete primary structure of human C4a anaphylatoxin.
1981
The scanning model for translation: an update.
1989 Standout
Pathophysiology and Pharmacological Treatment of Insulin Resistance*
2000
Isolation of cDNA clones specifying the fourth component of mouse complement and its isotype, sex-limited protein.
1984 StandoutNobel
Fibrinolytic Factors and the Risk of Myocardial Infarction or Sudden Death in Patients With Angina Pectoris
1996
Effect of PAI-1 levels on the molar concentrations of active tissue plasminogen activator (t-PA) and t-PA/PAI-1 complex in plasma
1990
C-Reactive Protein, a Sensitive Marker of Inflammation, Predicts Future Risk of Coronary Heart Disease in Initially Healthy Middle-Aged Men
1999 Standout
Endogenous fibrinolytic system in chronic large-vessel thromboembolic pulmonary hypertension.
1992
Global Fibrinolytic Capacity Is Decreased in Polycystic Ovary Syndrome, Suggesting a Prothrombotic State
2002
Works of N. A. Booth being referenced
Activation of single‐chain urokinase‐type plasminogen activator by platelet‐associated plasminogen: a mechanism for stimulation of fibrinolysis by platelets
2010
From famine to feast: the role of methylglyoxal production in Escherichia coli
1998
Plasminogen activator inhibitor (PAI‐1) in plasma and platelets
1988
Plasminogen activator inhibitors (PAI‐1 and PAI‐2) in normal pregnancies, pre‐eclampsia and hydatidiform mole
1993
THE EFFECTS OF CHRONIC SMOKING ON THE FIBRINOLYTIC POTENTIAL OF PLASMA AND PLATELETS
1997
Metformin Causes a Reduction in Basal and Post‐venous Occlusion Plasminogen Activator Inhibitor‐1 in Type 2 Diabetic Patients
1991
The bleeding disorder in acute promyelocytic leukaemia: fibrinolysis due to u‐PA rather than defibrination
1989
Circulating tissue-type plasminogen activator and plasminogen activator inhibitor type 1 in proliferative diabetic retinopathy: a pilot study
1999
Distribution of plasminogen activator inhibitor in normal liver, cirrhotic liver, and liver with metastases.
1994
The receptor for tissue plasminogen activator (t‐PA) in complex with its inhibitor, PAI‐1, on human hepatocytes
1991
Up-regulation of plasminogen activator inhibitor 2 (PAI-2) in response to α-lactalbumin
1999
The activity of plasminogen activator inhibitor-1 (PAI-1) of human platelet
1990
Opposing effects of interleukin-1 and transforming growth factor-beta on the regulation of tissue-type plasminogen activator and plasminogen activator inhibitor type-1 expression by human mesangial cells.
1997
Complexing of tissue plasminogen activator with PAI-1, alpha 2- macroglobulin, and C1-inhibitor: studies in patients with defibrination and a fibrinolytic state after electroshock or complicated labor
1990
Distribution of plasminogen activator inhibitor (PAI-1) in tissues.
1991
Definition of epitopes within plasminogen activator inhibitor type-1 (PAI-1) using multiple peptide synthesis
1993
A new life-long hemorrhagic disorder due to excess plasminogen activator
1983
An Enzyme-Linked Immunosorbent Assay (ELISA) Used to Study the Cellular Secretion of Endothelial Plasminogen Activator Inhibitor (PAI-1)
1988
Human Thrombi Contain an Abundance of Active Thrombin
2001
The purification and characterization of bovine C4, the fourth component of complement
1979
Platelet release protein which inhibits plasminogen activators.
1985
Plasmin‐a2‐antiplasmin complexes in bleeding disorders characterized by primary or secondary fibrinolysis
1984
The isolation and characterization of bovine C4a, an activation fragment of the fourth component of complement
1979